Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram abnormal, Computerised tomogram thorax, Dyspnoea, Mycobacterium tuberculosis complex test negative, Psoriasis
Clinical narrative: I was getting SOB, climbing on my staircase on 31May2021; 2 and half weeks after the 2nd vaccine ,i develop rashes in my chest- looking like psoriasis, they got more and more, slowly , till they cover my anterior chest, then posterior chest-very itchy . red,; 2 and half weeks after the 2nd vaccine ,i develop rashes in my chest- looking like psoriasis, they got more and more, slowly , till they cover my anterior chest, then posterior chest-very itchy . red,; 2 and half weeks after the 2nd vaccine ,i develop rashes in my chest- looking like psoriasis, they got more and more, slowly , till they cover my anterior chest, then posterior chest-very itchy . red,; 2 and half weeks after the 2nd vaccine ,i develop rashes in my chest- looking like psoriasis, they got more and more, slowly , till they cover my anterior chest, then posterior chest-very itchy . red,; CT chest with contrast has ground glass infiltrate; This is a spontaneous report from a contactable physician. A 70-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH mRNA COVID-19 VACCINE, Solution for injection, Lot number and Expiration date was not reported), via an unspecified route of administration, in Arm Left on Jan2021 as DOSE 2, SINGLE for Covid-19 immunisation. The patient medical history included was reported as none. Patient was allergic to Strong smell- like cigarette. The patient's concomitant medications were not reported. Patient received first dose of bnt162b2 (PFIZER-BIONTECH mRNA COVID-19 VACCINE, Solution for injection, Lot number: EK5730, El3302, Expiration date: not reported), via an Intramuscular route of administration, in left Arm on 22Dec2020 at 13:00 as DOSE 1, SINGLE for Covid-19 immunisation. Patient did not receive other vaccines in four weeks prior to the COVID vaccine. Patient did not receive other medications within two weeks. Patient was not diagnosed covid, prior vaccination. Since the vaccination, the patient was not tested positive for COVID-19. She was never sick till I had the covid-19 vaccine. Patient reported 2 and half weeks after the 2nd vaccine on 03Feb2021 at 8:00, i develop rashes in my chest looking like psoriasis, they got more and more, slowly, till they cover her anterior chest, then posterior chest-very itchy. red, she was applying hydrocortisone cream, then they went to her upper thighs, then few in the legs, on the last week of May2021, she was getting SOB, climbing my staircase, on 31May2021, she was very SOB, she was taken to hospital and stayed 3 days. Patient was hospitalized. The patient underwent lab tests and procedures which included CT chest with contrast has ground glass infiltrate, she was covid-19: negative all along even on 31May2021 in ER. She went to dermatologist negative TB gold test, Biopsy confirmed Psoriasis she just started on Skyrizi injection 25May2021, she was very miserable. The patient received treatment that she was administered Oxygen, Lasix. The outcome of the events CT chest with contrast has ground glass infiltrate was unknown and outcome for rest of events was not recovered. Device date was 29Jun2021.  Information on Lot/Batch number was available. Additional information has been requested.; Sender's Comments: Based on the known safety profile of the vaccine BNT162B2, a temporal relation between the events; rash, rash pruritic ,rash erythematous, psoriasis, dyspnea, CT abnormal and the administration of the vaccine cannot be excluded.The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events.  Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.